AGT and breast carcinoma: ER− (pII and MDA-MB-231) and ER+ (YS1.2) breast cancer cell lines were treated with various concentrations (0.1, 1, and 10 μM) of Ang II for 72 h, and cell morphology was monitored every 24 h under a light microscope.